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TO THE EDITOR
Cutaneous squamous cell carcinoma
(cSCC) is the second most common type
of non-melanoma skin cancer and is
dramatically increased in the setting
of immunosuppression such as organ
transplantation (Hartevelt et al., 1990;
Jensen et al., 1999; Lindelof et al., 2000;
Grulich et al., 2007). This magnitude
of increase is similar to that seen in virus-
related cancers, such as human herpes-
virus-8-mediated Kaposi’s sarcoma and
Epstein-Barr virus-related lymphoma
(Vajdic et al., 2006). There have been
multiple attempts to define a viral etio-
logy for cSCC and to link cSCC with
human papillomavirus (HPV). There is a
clear epidemiologic association between
HPV and cSCC (Aldabagh et al., 2012),
but detection has been limited to viral
DNA. Two studies have demonstrated
the absence of viral transcription in cSCC
RNAseq data, confirming that direct
viral transformation of keratinocytes is
not required for maintenance of tumor
(Arron et al., 2011; Ganzenmueller et al.,
2012). These data suggest that, if there
is a viral pathogen causing cSCC, the
mechanism of carcinogenesis is not
simply through expression of viral
oncogenes.
This raises the possibility of alternate
mechanisms of oncogenesis, including
insertional mutagenesis, in which viral
integration into the genome disrupts
human genes of cell cycle regulation
(Leib-Mosch et al., 1990). This would be
unlikely for a papillomavirus, but high-
risk a-papillomaviridae do aberrantly
integrate as part of cervical onco-
genesis (Wentzensen et al., 2004), and
it is possible that cutaneous b-papillo-
maviridae do the same. Alternately,
DNA from a previously undetected virus
may be integrated into the genome or
persist as extragenomic DNA. We used
a newly published software package,
Integrated Metagenomic Sequence Ana-
lysis (IMSA) (Dimon et al., 2013), to
address the hypothesis that HPV or
another virus may be integrated into the
cSCC genome or otherwise present in
cancer DNA.
Exome sequence from 12 cSCC and
patient-matched normal skin were
obtained from a previously reported
study (Durinck et al., 2011). Exome
sequence from the MCF7 breast cancer
cell line was used as a negative control.Accepted article preview online 30 January 2014; published online 27 February 2014
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Previously described WGS data from
SiHa and CaSki cell lines were used as
positive controls for the viral analysis
(Conway et al., 2012).
Pathogen analysis was performed
with IMSA (Dimon et al., 2013). Low
quality and human reads were filtered
against the human genome (hg19), and
nonhuman reads were aligned to the
National Centre for Biotechnology Infor-
mation (NCBI) nucleotide database. An
average of 9.4 107 reads was obtained
from each sample; 2.4105 nonhuman
reads remained after IMSA filtering
(0.25%). Nonhuman and intronic reads
in exome datasets result from incom-
plete capture efficiency. In order to
confirm our ability to detect potential
pathogen reads in exome datasets, we
measured the percent of aligned reads
on target using Picard. Picard is a set of
standard bioinformatics software tools
for high throughput sequence analysis.
The tools are open source and can be
found at http://picard.sourceforge.net/.
The specific tool that we used was
CalculateHsMetrics, which is designed
to measure the efficiency of targeted
sequencing such as exome sequencing.
Capture efficiencies ranged between
66.1 and 78.1%. On average, 27.3%
of the reads in each dataset were non-
exome. These libraries were sequenced
to great depth for the purpose of
cancer mutation analysis, therefore
ample sequence was available for
metagenomics.
IMSA generates a quantitative score
for each taxonomic node, reflective of
the level of nonhost DNA. To compare
between datasets, we normalized
the taxonomy score per million reads.
cSCC had more bacterial reads on aver-
age than normal skin (65% vs. 33% of
nonhuman reads, Figure 1). In total,
16% of cSCC and 30% of normal non-
human reads mapped to vertebrates,
most commonly nonhuman primate.
These likely represent human DNA with
sufficient divergence or sequencing
errors to pass through the filters.
A total of 1% or fewer reads mapped
to virus (Figure 2). The median-normal-
ized score for cSCC samples was 0.26
(interquartile range (IQR) 0.1–0.7), no
different from normal tissue (0.24, IQR
0.06–0.9, paired t-test P¼ 0.3). In con-
trast, SiHa had a score of 6.25 and
CaSki had a score of 1,272.6, derived
exclusively from HPV16 reads.
One exome set contained signifi-
cantly higher viral read scores, 6.2 in
tumor and 36.3 in normal skin. These
reads were derived from torque teno
virus (TTV). TTV is an ubiquitous
3.8-Kb circular single-stranded DNA
virus that has not been associated
with disease. TTV viremia reflects
immune function (Moen et al., 2003),
and this tumor-normal pair was from an
immunosuppressed lung transplant
recipient. Two of these reads indicated
integration into the human genome.
To maximize the probability of
detecting pathogen, we also examined
WGS from three tumor-normal pairs.
Normal skinSCC
Plant (inc. fungi); 0% Plant (inc. fungi); 0%
Other; 19%
Other; 36%
Vertebrate; 16%
Vertebrate; 30%
Bacteria; 65%
Bacteria; 33%
Virus; 0% Virus; 1%
Figure 1. Taxonomic classification of nonhuman reads in cSCC and normal skin. The percents shown are
rounded to the nearest integer. In viral samples, the average percent viral reads is 0.145%, whereas in
normal skin the average percent viral reads is 1.139%.
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Figure 2. Viral sequence scores per million sequence reads.
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Whole-genome sequence (WGS) libra-
ries were prepared with the NuGEN
Ovation Ultralow Library System and
sequenced with the Illumina sequen-
cing-by-synthesis platform. In total,
3108 reads were obtained from each
WGS readset; with over 2 106 nonhu-
man reads remaining after IMSA filter-
ing. The tumor-normal pairs had
normalized viral read scores within the
background range; 0.04/0.06, 0.24/
0.08, and 0.01/0.05, (P¼ 0.9, 95% con-
fidence interval  0.6–0.6) (Figure 2).
These data demonstrate the absence
of viral DNA, including HPV DNA, in
the exome and WGS of cSCC. This is
consistent with prior quantitative reverse
transcriptase in real time data demon-
strating extraordinarily low HPV DNA
copy number in cSCC (typically less
than one copy per 100 cells) (Arron
et al., 2011), and with the newly deve-
loping consensus that viral infection is
not required for tumor maintenance. In
contrast, viral DNA was readily detected
in two cervical cancer cell lines, CaSki
and SiHa.
Despite these findings, the consistent
association of HPV DNA with cSCC
remains unclear. One remaining possi-
bility is a hit-and-run mechanism, by
which the virus destabilizes the kerati-
nocyte until sufficient UV-mediated
DNA mutations accumulate for trans-
formation. This proposed role for viral
tumor induction would be compatible
with existing sequencing data, which
has been limited to invasive tumor
tissue.
It is possible that virus has no role in
cSCC, but is rather a marker of cuta-
neous immunosuppression. This would
explain the predilection of HPV for
sun-exposed skin and the increased
prevalence of HPV in the skin of
immunosuppressed patients (Aldabagh
et al., 2012). Our finding of TTV in the
tumor and adjacent normal skin of a
lung transplant recipient suggests that
immunosuppression predisposes to
unrelated viral carriage.
It remains imperative to determine
whether cSCC is a viral cancer, as this
would have major implications for
patient risk assessment and screening.
Identifying a causative virus would
open avenues for improved detection,
targeted molecular therapies, and a
potential vaccine for cancer prophy-
laxis. Additional studies may continue
to shed light on this controversial and
important subject.
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